Literature DB >> 24157448

Ghrelin and obestatin levels in children with failure to thrive and obesity.

Prateek Wali1, Jeremy King, Zhaoping He, Dalal Tonb, Karoly Horvath.   

Abstract

OBJECTIVES: Ghrelin and obestatin are 2 gastric hormones with opposite effects on food intake and body weight. We investigated plasma ghrelin and obestatin in children with failure to thrive (FTT) and obesity as compared with age-matched controls.
METHODS: A total of 63 children were included in the study: 13 with FTT, 17 with obesity, and 33 age-matched controls. Children fasted for at least 8 hours before specimen collection. Both hormones were measured using commercially available enzyme immunoassay kits.
RESULTS: Ghrelin and obestatin levels in children with FTT were not significantly different from that of the age-matched controls (P >0.05). In children with obesity, the total ghrelin levels were significantly lower (P = 0.0003) and the obestatin levels significantly higher (P = 0.029) compared with those in controls. In the control group, the fasting ghrelin level was significantly higher in the younger (<3 years) than in the older children (>3 years; P = 0.0004). Obestatin levels correlated positively with weight-for-age percentiles in the obese group (P = 0.011) and negatively in the control group >3 years (P = 0.019).
CONCLUSIONS: Compared with the levels in age-matched controls, fasting ghrelin and obestatin levels did not differ significantly in children with FTT. In the children with obesity, the decreased ghrelin and increased obestatin levels suggest a possible adaptive process to positive energy balance. Ghrelin had pronounced age-related changes, and obestatin was associated with the weight status. This may suggest that these 2 hormones use different mechanisms to regulate energy balance and weight.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24157448     DOI: 10.1097/MPG.0000000000000223

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

Authors:  María José Franco-Tormo; Mireille Salas-Crisostomo; Nuno Barbosa Rocha; Henning Budde; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  J Mol Neurosci       Date:  2018-05-07       Impact factor: 3.444

Review 2.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

3.  Helicobacter pylori infection and serum leptin, obestatin, and ghrelin levels in Mexican schoolchildren.

Authors:  Carolina Romo-González; Eugenia Mendoza; Robertino M Mera; Rafael Coria-Jiménez; Patricia Chico-Aldama; Rita Gomez-Diaz; Ximena Duque
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

4.  Serum ghrelin levels and gender-related indices of body composition in prepubertal children: a cross-sectional study.

Authors:  Minoo Bagheri; Sara Ansari; Gity Sotoudeh; Mahmood Mahmoudi; John R Speakman; Kurosh Djafarian
Journal:  Eur J Nutr       Date:  2014-05-08       Impact factor: 5.614

Review 5.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

6.  An Evaluation of Acylated Ghrelin and Obestatin Levels in Childhood Obesity and Their Association with Insulin Resistance, Metabolic Syndrome, and Oxidative Stress.

Authors:  Maryam Razzaghy-Azar; Mitra Nourbakhsh; Abdolreza Pourmoteabed; Mona Nourbakhsh; Davod Ilbeigi; Mohsen Khosravi
Journal:  J Clin Med       Date:  2016-06-23       Impact factor: 4.241

7.  Treatment with Obestatin-A Ghrelin Gene-Encoded Peptide-Reduces the Severity of Experimental Colitis Evoked by Trinitrobenzene Sulfonic Acid.

Authors:  Katarzyna Konarska; Jakub Cieszkowski; Zygmunt Warzecha; Piotr Ceranowicz; Anna Chmura; Beata Kuśnierz-Cabala; Krystyna Gałązka; Paweł Kowalczyk; Andrzej Miskiewicz; Thomas Jan Konturek; Michał Pędziwiatr; Artur Dembiński
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

8.  The associations between some biological markers, obesity, and cardiovascular risk in Slovenian children and adolescents.

Authors:  Nataša Marčun Varda; Martina Medved; Laura Ojsteršek
Journal:  BMC Pediatr       Date:  2020-02-21       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.